Volume 16 Supplement 2
Publication of this supplement has been supported by the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) through a Planning and Dissemination Grant. Another important supporting partner in the Afri-Can Forum 2 was the Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO).
Johannesburg, South Africa16-18 February 2015
A1 Introduction to the 2nd synchronicity forum of GHRI/CHVI-funded Canadian and African HIV prevention and vaccine teams
Citation: BMC Infectious Diseases 2016 16(Suppl 2):315
Speed
78 days to first decision for reviewed manuscripts only
49 days to first decision for all manuscripts
184 days from submission to acceptance
14 days from acceptance to publication
Citation Impact
3.090 - 2-year Impact Factor
3.401 - 5-year Impact Factor
1.581 - Source Normalized Impact per Paper (SNIP)
1.278 - SCImago Journal Rank (SJR)
Usage
5,251,510 Downloads
4,959 Altmetric Mentions
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.